Member Info for Showmedamane

Seems whichever way the pandemic turns the company has it covered

The company have stated in the annual report that at the start of the pandemic there was a worldwide ide focus on herd immunity with the aide of antibody testing . This shifted to pcr testing but now that with vaccines and past infection they anticipate it will shift back to antibody testing. This now looks proven to be true. If you’ve not read it check it out on companies house 14.12

Apologies if this is common knowledge but has the Vatic test and the abc19 test always been on the bio user website?

https://biosuretest.com/

Explains biosure site down for maintenance and sold out everywhere- get ready for the kaboom

So the price is below the recent placing which is equates to less than the asset value , the directors have purchased £500k more shares whilst knowing the issues stated in the last rns, jobs are being advertised claiming ‘ exciting growth’, worse case scenario Covid is changing from a pandemic to an endemic which means testing required for eternity and also more emphasis on antibody testing . Lateral flows space will only get bigger due to the whole planet becoming accustom to them. Multiple imminent announcements due any moment - this will prove to be bargain of the century just a case of waiting and not very long imo

‘The UK government must urgently review their validation approach for superior UK manufactured lateral flow devices. They must show the same confidence the rest of the world has for emerging rapid artificial intelligence Cpvid tests.

Covid is part of our new reality, and it is incumbent on government to develop a resilient and accurate testing strategy that keeps us safe and secures domestic innovation, industry and employment into the future.’

https://mobile.twitter.com/JNHanvey/status/1481694609826799621?t=bYUNlV1oWfASI5WTP-i3NQ&s=19

https://biosuretest.com/products/biosure-covid-19-antibody-self-testing-kit

All sold out - I believe antibody testing is the big draw here - was similar back in November according to their Twitter acc which was prior to there massive director buys so taking it as a big plus

It seems tactical to me if the test has been approved by the Eu and the tt was completed mid December then you would just go with it if it mean raking in millions unless there was bigger returns to be made by doing this. I am hoping a target for sensitivity has been given with the reward of a massive contract if achieved. Either from the Germans or a u turn from the U.K. - that way they can make out they were right initially but now this improvement has been made they can now reward a U.K. manufacturer

https://www.reuters.com/world/europe/germany-assessing-reliability-antibody-tests-omicron-minister-2022-01-09/

When the outcome of this review happens it will be a race to who has the most effective lft - hopefully acting now will put us ahead of the game - no point selling now at this price

Former Odx ceo offering six figure sum for a whistleblower leading to conviction

https://mobile.twitter.com/RmJrb/status/1480219699992485895

So does this mean that the abc test is no longer for commercial use only ?

The Abc-19 rapid test is produced by the UK-RTC (UK-Rapid Consortium) and have been purchased by the UK Government as part of the endeavour to keep life, business and wellbeing moving onwards through this pandemic.

Thanks

This seems to be creeping back up quietly on low volume :)

Journalist from the Sunday times has approached investors on Twitter so we may hear something soon from them

What’s with all the tiny buys at 24p seems odd

https://www.bbc.co.uk/news/live/uk-59825655

How many U.K. manufacturers would be required to make 300m lft per month? Anyone know the capacity of each U.K. manufacturer?

Can’t believe Sajid Javid has stated a U.K. manufacturer has x 4 there capacity and they are buying the lot .. fingers crossed for tmrw